Comparison of dimethyl fumarate and interferon outcomes in an MS cohort

Overview of attention for article published in BMC Neurology, July 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

Disease-modifying therapy use and health resource utilisation associated with multiple sclerosis over time: A retrospective cohort study from Alberta, Canada

Article in Journal of the Neurological Sciences (February 2024)

The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial

Article in Journal of Neurology (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.